Skip to main content

Zetia News

When Statins Aren't Enough, This Drug May Help Lower 'Bad' Cholesterol

THURSDAY, May 8, 2025 — A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing o...

Two-Drug Combo of a Statin Plus Ezetimibe, Lowers Cholesterol Better Than Statins Alone

TUESDAY, March 25, 2025 – Statins are very cheap and highly effective cholesterol-lowering drugs – but high-risk heart patients may have an even better option, a new evidence review says. Combining...

FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol

Friday, May 3, 2013 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Liptruzet (ezetimibe and atorvastatin)...

FDA Medwatch Alert: Ezetimibe/Simvastatin (Vytorin); Simvastatin (Zocor); and Ezetimibe (Zetia)

[Posted 08/21/2008] FDA informed healthcare professionals that the Agency is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a possible association...

FDA Medwatch Alert: Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor)

[Posted 01/25/2008] FDA provided healthcare professionals with an early communication about an ongoing data review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

High Cholesterol - Familial Heterozygous, High Cholesterol

Zetia patient information at Drugs.com